PB Fintech share price jumped 9% to ₹1,570.30 apiece on Thursday, February 5, after the company announced cancellation of its board meeting to discuss Qualified Institutions Placement (QIP).
“We wish to inform you that the meeting of the Board of Directors of the Company, which was scheduled to be held today, February 05, 2026, to discuss potential Qualified Institutions Placement (QIP) has been cancelled,” the company said in an exchange filing dated February 5.
On Monday, the company said its board assessed PB Fintech’s organic growth path and deliberated on plans to complement it through selective acquisitions and strategic investments in both domestic and overseas markets.
“The Board of Directors of PB Fintech Ltd (“Company”), at its meeting held earlier today, noted the Company’s robust organic growth trajectory over the years and discussed its strategy to complement this by selectively pursuing inorganic opportunities in local and/or international markets, through strategic investments, acquisitions and/or partnerships,” said the filing.
The company said the proposed fundraise will be carried out through a qualified institutional placement (QIP) of equity shares to eligible institutional investors, subject to necessary shareholder and regulatory approvals.
It added that the funds raised will be deployed for strategic investments, acquisitions, and partnerships, though no specific acquisition has been identified at this stage.
Why did the stock rise?
PB Fintech share price gained momentum after the company’s announcement to cancel Thursday’s board meet to discuss raising funds via QIP method.
According to brokerage firm JM Financial, the company already holds a cash reserve of over ₹50 billion, and the move to raise funds via a QIP points to a sizeable acquisition that could lead to a 5–6% equity dilution.
The brokerage firm further explained that though the management has indicated that the acquisition would be EPS-accretive, it would need to be executed at a meaningful valuation discount, as Indian markets are unlikely to assign the company’s current trading multiple to the overseas business.
“The company is already sitting on an ₹50 billion plus cashpile, the requirement of a QIP suggests a large acquisition, potentially resulting in 5-6% dilution. While management suggested the acquisition would be EPS-accretive, it would need to be at a significant valuation discount as Indian markets are unlikely to ascribe PB’s current trading multiple for the international entity,” the brokerage firm said.
PB Fintech Q3 results 2025
Net profit climbed 166% year-on-year (YoY) to ₹189 crore from ₹71 crore in the year-ago period, while revenue increased 37% YoY to ₹1,771 crore, up from ₹1,291 crore.
EBITDA surged to ₹158.8 crore from ₹27.6 crore, with margins expanding sharply to 9% compared with 2.1% in the same period last year.
New protection premiums rose 68% year-on-year, led by nearly 80% growth in health insurance. Revenue from new initiatives rose 41% YoY. Adjusted EBITDA margins in this segment improved to -3% this quarter from -7% a year ago, while contribution margins turned positive at around 6%.
PB Fintech shares are listed on both BSE and NSE. The stock hit a 52-week high of ₹1978 on June 17, 2025 and a 52-week low of ₹1,311.35 on March 12, 2025.
Disclaimer: This story is for educational purposes only. Please consult with an investment advisor before making any investment decisions.
